Hollings Cancer Center | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

117,621 results for “Hollings Cancer Center”

Trials

View all 94437 →

Hollings Cancer Center Varenicline Sampling Study

99 participants · First posted Nov 15, 2018

Teens Taking Charge: Managing Cancer Online

73 participants · First posted Nov 24, 2014

Arizona Cancer Center Biospecimen Repository

10,000 participants · First posted May 12, 2009

Drugs

View all 2497 →

Fecal Microbiota Transplantation（German Cancer Research Center）

Neoantigen-Targeted ppDC Vaccine(Uclas Jonsson Comprehensive Cancer Center)

Human papillomavirus tumor antigen vaccine (Vanderbilt University/Ingram Cancer Center)

Organizations

View all 1968 →

CENTER WEST CANCER

United States

Providence Cancer Center

NATIONAL CANCER CENTER

Japan

News

View all 18719 →

MUSC Hollings Cancer Center Launches AUTOMAIN Trial Testing Repurposed Drugs for Recurrent Ovarian Cancer

MUSC Health Breaks Ground on Indian Land Medical Center, Expanding Cancer and Specialty Care Across South Carolina

Bicara Launches Pivotal Phase 2/3 Trial of Novel Bifunctional Antibody for Advanced Head and Neck Cancer

Page 1 of 11763